DR. ALLYSON LYNN HARROFF M.D. NPI 1538291380

NPI Information

  • NPI: 1538291380
  • Provider Name: DR. ALLYSON LYNN HARROFF, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 2130 N.E.LOOP 410
    SUITE #100
    SAN ANTONIO, TX
    ZIP 78217
  • Phone: (210) 656-7177

Map and Directions

Get Directions

NPI Details

DR. Allyson Lynn Harroff, M.D. is a hematology and oncology internal medicine in San Antonio, TX with 27 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Allyson Lynn Harroff, M.D. NPI is 1538291380. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: MEDICAL COLLEGE OF OHIO
Graduation Year:1998

The provider's business location address is:

2130 N.E.LOOP 410
SUITE #100
SAN ANTONIO, TX
ZIP 78217-660
Phone: (210) 656-7177
Fax: (210) 656-3687

The NPI 1538291380 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev (HCPCS:G6013)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session (HCPCS:G6015)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Unclassified drugs (HCPCS:J3490)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Protein measurement, serum (HCPCS:84165)
  • Reticulated (young) platelet measurement (HCPCS:85055)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Blood test, clotting time (HCPCS:85610)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Folic acid level, serum (HCPCS:82746)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Red blood count automated, with additional calculations (HCPCS:85046)

The enumeration date for this NPI number is 3/9/2007 and was last updated on 7/28/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical OncologyM3251TEXASNo
2207RH0003XInternal MedicineHematology & OncologyM3251TEXASYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
18AA841OTHERTEXASBLUECROSS/BLUESHIELD TX.
2P01547658OTHERTEXASRAILROAD MEDICARE
3185867201MEDICAIDTEXAS
4185867202MEDICAIDTEXAS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.